Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells

[1]  V. Macrae,et al.  A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification , 2016, Vascular pharmacology.

[2]  F. Lang,et al.  Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine. , 2016, Cardiovascular research.

[3]  Lee B. Smith,et al.  Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification , 2016, Scientific Reports.

[4]  M. Liechti,et al.  Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects , 2016, Journal of neuroendocrinology.

[5]  M. Bertog,et al.  Aldosterone synthase knockout mouse as a model for sodium‐induced endothelial sodium channel up‐regulation in vascular endothelium , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Tokumoto,et al.  Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. , 2015, American journal of physiology. Renal physiology.

[7]  R. Touyz,et al.  Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling , 2015, Front. Physiol..

[8]  E. Schleicher,et al.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency. , 2015, Journal of the American Society of Nephrology : JASN.

[9]  C. Wagner,et al.  Mechanisms of renal control of potassium homeostasis in complete aldosterone deficiency. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  H. Ohtsu,et al.  Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial. , 2014, The lancet. Diabetes & endocrinology.

[11]  F. Lang,et al.  Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification , 2014, Nephron Physiology.

[12]  Alexandra S. Straeter,et al.  Feedforward activation of endothelial ENaC by high sodium , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma , 2014, Journal of Molecular Medicine.

[14]  A. Lichtenberg,et al.  The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model. , 2014, Biomaterials.

[15]  J. Loscalzo,et al.  Upregulation of Steroidogenic Acute Regulatory Protein by Hypoxia Stimulates Aldosterone Synthesis in Pulmonary Artery Endothelial Cells to Promote Pulmonary Vascular Fibrosis , 2014, Circulation.

[16]  N. Freemantle,et al.  Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial , 2014, Trials.

[17]  Jenny B. Koenig,et al.  Direct Role for Smooth Muscle Cell Mineralocorticoid Receptors in Vascular Remodeling: Novel Mechanisms and Clinical Implications , 2014, Current Hypertension Reports.

[18]  S. Kageyama,et al.  Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. , 2014, Journal of the American College of Cardiology.

[19]  M. Omura,et al.  Vascular Aldosterone Production at the Pre-Diabetic Stage of Young Otsuka Long-Evans Tokushima Fatty (OLETF) Rats, Compared with Long-Evans Tokushima Otsuka (LETO) Rats , 2013, Molecules.

[20]  F. Lang,et al.  25-Hydroxyvitamin D3 1-Alpha-Hydroxylase-Dependent Stimulation of Renal Klotho Expression by Spironolactone , 2013, Kidney and Blood Pressure Research.

[21]  Cuk-Seong Kim,et al.  Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1. , 2013, Biochemical and biophysical research communications.

[22]  F. Lang,et al.  Vascular calcification--is aldosterone a culprit? , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  K. Rosenblatt,et al.  Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. , 2013, The Journal of clinical investigation.

[24]  C. Arrowsmith,et al.  Structural insights into aldosterone synthase substrate specificity and targeted inhibition. , 2013, Molecular endocrinology.

[25]  Takashi Kobayashi,et al.  Trichostatin A, an HDAC class I/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. , 2013, Journal of atherosclerosis and thrombosis.

[26]  C. Wagner,et al.  Aldosterone deficiency adversely affects pregnancy outcome in mice , 2012, Pflügers Archiv - European Journal of Physiology.

[27]  J. Connell,et al.  APEX1 Regulation of Aldosterone Synthase Gene Transcription Is Disrupted by a Common Polymorphism in Humans , 2012, Circulation research.

[28]  Yan Cai,et al.  Endogenous aldosterone is involved in vascular calcification in rat , 2012, Experimental biology and medicine.

[29]  C. Shanahan,et al.  Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate , 2011, Circulation research.

[30]  K. Fujisaki,et al.  Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  C. Giachelli,et al.  Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. , 2011, The American journal of pathology.

[32]  Á. Millán,et al.  Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. , 2011, American journal of physiology. Cell physiology.

[33]  K. Rosenblatt,et al.  Hyperaldosteronism in Klotho-deficient mice. , 2010, American journal of physiology. Renal physiology.

[34]  Xianwu Li,et al.  Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis , 2010, Journal of cellular biochemistry.

[35]  Y. Ouchi,et al.  Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification* , 2010, The Journal of Biological Chemistry.

[36]  L. Schurgers,et al.  Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. , 2010, Journal of the American Society of Nephrology : JASN.

[37]  Y. Maehara,et al.  The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells , 2009, Hypertension Research.

[38]  P. Schirmacher,et al.  Arterial calcification in patients with chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  D. Towler,et al.  Vascular calcification: the killer of patients with chronic kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[40]  L. Schurgers,et al.  Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis , 2008, Circulation.

[41]  J. Qu,et al.  Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of Cysteines 93 and 310 , 2007, Nucleic acids research.

[42]  Y. Tintut,et al.  Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[43]  R. Bigazzi,et al.  Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. , 2006, Kidney international.

[44]  Xianwu Li,et al.  Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification , 2006, Circulation research.

[45]  M. Pfeffer,et al.  Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease , 2005, Circulation.

[46]  H. Siragy,et al.  Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor , 2005, Hypertension.

[47]  Su‐Li Cheng,et al.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. , 2005, The Journal of clinical investigation.

[48]  M. Mendelsohn,et al.  Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells , 2005, Circulation research.

[49]  C. Gomez-Sanchez,et al.  Do human vascular endothelial cells produce aldosterone? , 2004, Endocrinology.

[50]  C. Giachelli.  Vascular calcification: in vitro evidence for the role of inorganic phosphate. , 2003, Journal of the American Society of Nephrology : JASN.

[51]  D. Mooney,et al.  Cyclic strain inhibits switching of smooth muscle cells to an osteoblast‐like phenotype , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[53]  C. Gomez-Sanchez,et al.  Cardiac Steroidogenesis—New Sites of Synthesis, or Much Ado About Nothing? , 2001 .

[54]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[55]  C. Gomez-Sanchez,et al.  Editorial: Cardiac steroidogenesis--new sites of synthesis, or much ado about nothing? , 2001, The Journal of clinical endocrinology and metabolism.

[56]  K. Weber,et al.  Extra-adrenal mineralocorticoids and cardiovascular tissue. , 1999, Journal of molecular and cellular cardiology.

[57]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[58]  I. Miyamori,et al.  Vascular aldosterone in genetically hypertensive rats. , 1997, Hypertension.

[59]  畠山 治彦.  Vascular aldosterone : biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells , 1995 .

[60]  T. Kawamoto,et al.  Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Waterman,et al.  Neurosteroids: cytochrome P-450scc in rat brain. , 1987, Science.

[62]  G. Owens,et al.  Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation , 1986, The Journal of cell biology.

[63]  R. Hené,et al.  Plasma aldosterone concentrations in chronic renal disease. , 1982, Kidney international.